Novartis names Strigini president of Novartis Oncology

Novartis AG (NYSE:NVS; SIX:NOVN) hired Bruno Strigini as president of the pharma's Novartis Oncology business. He was president of Europe/Canada at Merck & Co. Inc. (NYSE:MRK). Strigini replaces Alessandro Riva, who has been serving as interim president of Novartis Oncology since Herve Hoppenot departed in January. Riva is global head of oncology development and medical affairs at Novartis. ...